Prothena Corp Public (PRTA) Change in Receivables (2014 - 2024)
Prothena Corp Public (PRTA) posted quarterly Change in Receivables of -$5.2 million for Q1 2024, down 211.31% quarter-over-quarter from $4.6 million in Q3 2023.
Prothena Corp Public (PRTA) Change in Receivables (2014 - 2024) Analysis & Trends
Prothena Corp Public's Change in Receivables history runs 10 years deep, the most recent figure standing at -$5.2 million for Q1 2024.
- In Q1 2024, Change in Receivables changed N/A year-over-year to -$5.2 million; the TTM figure through Dec 2024 stood at -$5.2 million (down 200.0% YoY), while the FY2024 annual figure was -$5.2 million, down 200.0% from the prior year.
- Change in Receivables for Q1 2024 stood at -$5.2 million, down from $4.6 million in the prior quarter.
- The five-year high for Change in Receivables was $4.6 million in Q3 2023, with the low at -$5.2 million in Q1 2024.
- The 4-year median for Change in Receivables is -$7000.0 (2020), against an average of -$6181.8.
- Peak annual rise in Change in Receivables reached 2020.0% in 2020, while the deepest fall reached 1585.71% in 2020.
- Prothena Corp Public's Change in Receivables stood at -$7000.0 in 2020, then sank by 1028.57% to -$79000.0 in 2021, then surged by 5967.09% to $4.6 million in 2023, then sank by 211.31% to -$5.2 million in 2024.
- Business Quant data shows PRTA's Change in Receivables at -$5.2 million in Q1 2024, $4.6 million in Q3 2023, and $524000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -5.16 Mn |
| Mar 31, 2024 | -5.16 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 524,000.00 |
| Jun 30, 2023 | 524,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Dec 31, 2021 | -79,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Sep 30, 2021 | 76,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Mar 31, 2021 | -14,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Dec 31, 2020 | -7,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Jun 30, 2020 | -118,000.00 |
| Jun 30, 2020 | -118,000.00 |